These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25851836)

  • 1. Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties.
    Kobayashi A; Matsuura Y; Iwaki T; Iwasaki Y; Yoshida M; Takahashi H; Murayama S; Takao M; Kato S; Yamada M; Mohri S; Kitamoto T
    Brain Pathol; 2016 Jan; 26(1):95-101. PubMed ID: 25851836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?
    Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T
    J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
    Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
    Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creutzfeldt-Jakob disease.
    Sikorska B; Knight R; Ironside JW; Liberski PP
    Adv Exp Med Biol; 2012; 724():76-90. PubMed ID: 22411235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease.
    Gelpi E; Baiardi S; Nos C; Dellavalle S; Aldecoa I; Ruiz-Garcia R; Ispierto L; Escudero D; Casado V; Barranco E; Boltes A; Molina-Porcel L; Bargalló N; Rossi M; Mammana A; Tiple D; Vaianella L; Stoegmann E; Simonitsch-Klupp I; Kasprian G; Klotz S; Höftberger R; Budka H; Kovacs GG; Ferrer I; Capellari S; Sanchez-Valle R; Parchi P
    Acta Neuropathol Commun; 2022 Aug; 10(1):114. PubMed ID: 35978418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-occurrence of types 1 and 2 PrP(res) in sporadic Creutzfeldt-Jakob disease MM1.
    Kobayashi A; Mizukoshi K; Iwasaki Y; Miyata H; Yoshida Y; Kitamoto T
    Am J Pathol; 2011 Mar; 178(3):1309-15. PubMed ID: 21356381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    J Biol Chem; 2007 Oct; 282(41):30022-8. PubMed ID: 17709374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
    Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
    Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions.
    Taguchi Y; Mohri S; Ironside JW; Muramoto T; Kitamoto T
    Am J Pathol; 2003 Dec; 163(6):2585-93. PubMed ID: 14633630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.
    Collins SJ; Sanchez-Juan P; Masters CL; Klug GM; van Duijn C; Poleggi A; Pocchiari M; Almonti S; Cuadrado-Corrales N; de Pedro-Cuesta J; Budka H; Gelpi E; Glatzel M; Tolnay M; Hewer E; Zerr I; Heinemann U; Kretszchmar HA; Jansen GH; Olsen E; Mitrova E; Alpérovitch A; Brandel JP; Mackenzie J; Murray K; Will RG
    Brain; 2006 Sep; 129(Pt 9):2278-87. PubMed ID: 16816392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.
    Kobayashi A; Matsuura Y; Mohri S; Kitamoto T
    Acta Neuropathol Commun; 2014 Mar; 2():32. PubMed ID: 24685293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt-Jakob disease with codon 219 lysine allele observed in Japanese population.
    Ikawa M; Yoneda M; Matsunaga A; Nakagawa H; Kazama-Suzuki A; Miyashita N; Naiki H; Kitamoto T; Kuriyama M
    J Neurol Sci; 2009 Oct; 285(1-2):265-7. PubMed ID: 19666177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.
    Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I
    Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type.
    Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P
    Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease.
    Kobayashi A; Iwasaki Y; Takao M; Saito Y; Iwaki T; Qi Z; Torimoto R; Shimazaki T; Munesue Y; Isoda N; Sawa H; Aoshima K; Kimura T; Kondo H; Mohri S; Kitamoto T
    Am J Pathol; 2019 Jun; 189(6):1276-1283. PubMed ID: 30926338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.